L. Millner

Most-cited papers

1. Circulating Tumor Cells: A Review of Present Methods and the Need to Identify Heterogeneous Phenotypes

   L. Millner, M. Linder, R. Valdes

   2013Annals of Clinical and Laboratory Science156 citations

   Semantic Scholar

   Save

2. The Future of Precision Medicine in Oncology.

   L. Millner, L. Strotman

   2016Clinics in Laboratory Medicine54 citations

   Semantic Scholar

   Save

3. Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review

   D. Hein, L. Millner

   2020Expert Opinion on Drug Metabolism & Toxicology32 citations Open access

   Semantic Scholar

   Save

4. Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations

   Jean Bendaly, M. Doll, L. Millner, Kristin J. Metry +3 more

   2009Mutation research29 citations Open access

   Semantic Scholar

   Save

5. Liquid Biopsies in Oncology and the Current Regulatory Landscape

   L. Strotman, L. Millner, R. Valdes, M. Linder

   2016Molecular Diagnosis & Therapy28 citations

   Semantic Scholar

   Save

6. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct.

   L. Millner, M. Doll, Marcus W. Stepp, J. States +1 more

   2012Carcinogenesis19 citations Open access

   Semantic Scholar

   Save

7. Phenotype of the Most Common “Slow Acetylator” Arylamine N-Acetyltransferase 1 Genetic Variant (NAT1*14B) Is Substrate-Dependent

   L. Millner, M. Doll, Jian Cai, J. States +1 more

   2012Drug Metabolism And Disposition17 citations Open access

   Semantic Scholar

   Save

8. Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype.

   D. Hein, L. Millner, C. Leggett, M. Doll

   2010Carcinogenesis9 citations Open access

   Semantic Scholar

   Save

9. A clinical approach to solving discrepancies in therapeutic drug monitoring results for patients on sirolimus or tacrolimus: Towards personalized medicine, immunosuppression and pharmacogenomics.

   L. Millner, C. Rodriguez, S. Jortani

   2015Clinica chimica acta; international journal of clinical chemistry8 citations

   Semantic Scholar

   Save

10. Abstract 2730: Image-based single cell-sorting to separate and recover distinct cell populations from complex heterogeneous mixed tissue: precise sample preparation upstream of FISH

    A. Gerber, A. Khurana, Lisa Koenig, L. Strotoman +9 more

    20170 citations

    Semantic Scholar

    Save

11. Abstract P5-03-10: Development of a novel HER2 testing strategy, using image-based cell-sorting to isolate pure cell populations from FFPE upstream of FISH

    A. Gerber, L. Konig, L. Millner, L. Strotoman +5 more

    20170 citations

    Semantic Scholar

    Save

12. Inter-laboratory evaluation of a novel DEPArray-HER2 FISH assay.

    A. Gerber, Lisa Koenig, L. Millner, L. Strotman +4 more

    20170 citations

    Semantic Scholar

    Save

13. Comprehensive isolation, identification, and nucleic acid analysis of single breast cancer cells: CTC-isoTECH

    L. Millner, L. Strotman, K. Goudy, M. Linder +1 more

    20160 citations Open access

    Semantic Scholar

    Save

14. Functional analysis of N-acetyltransferase (NAT1*14B and NAT1*10) in complete NATb and NATa mRNA.

    L. Millner

    20110 citations Open access

    Semantic Scholar

    Save

15. N-Acetyltransferase 1 Polymorphism and Breast Cancer Risk

    L. Millner

    20110 citations Open access

    Semantic Scholar

    Save

16. Effect of N-acetyltransferase (NAT1 ) polymorphism on mutagenesis and DNA adduct formation

    L. Millner

    20080 citations

    Semantic Scholar

    Save

17. Abstract B77: Translational effects of alternative NAT1 mRNA isoforms

    L. Millner, David F. Barker, Ashley L Howarth, M. Doll +2 more

    20080 citations

    Semantic Scholar

    Save